Coroflo
Founded Year
2016Stage
Unattributed - II | AliveTotal Raised
$7.59MLast Raised
$3M | 7 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+376 points in the past 30 days
About Coroflo
Coroflo focuses on innovative technology in the healthcare sector. The company's main product is a nipple shield with inbuilt flow measurement that transfers data to an app, providing accurate, precise, data on breastfeeding. This product primarily caters to the healthcare industry, specifically new mothers and healthcare professionals. It was founded in 2016 and is based in Dublin11, Ireland.
Loading...
ESPs containing Coroflo
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The connected breastfeeding pumps & wearables market offers alternatives for breastfeeding through discreet and portable hardware, integrated sensors, and apps that help mothers track feeding schedules and optimize milk supply. These technologies provide assistance and guidance to mothers while monitoring breastfeeding and infant care. This market leverages the use of smartphones to support mother…
Coroflo named as Challenger among 7 other companies, including Elvie, Willow, and Medela.
Loading...
Research containing Coroflo
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Coroflo in 2 CB Insights research briefs, most recently on Mar 28, 2024.
Mar 28, 2024
The femtech market mapNov 11, 2022 report
How tech is making women’s healthcare more equitable and accessibleExpert Collections containing Coroflo
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Coroflo is included in 1 Expert Collection, including Baby and Kids Tech.
Baby and Kids Tech
1,281 items
Companies developing tech-enabled products and services that primarily serve babies, children up to approximately 12 years old, and their parents.
Coroflo Patents
Coroflo has filed 2 patents.
The 3 most popular patent topics include:
- breast milk
- breastfeeding
- fluid dynamics
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
7/18/2019 | 8/6/2024 | Breastfeeding, Fluid dynamics, Fluid mechanics, Infant feeding, Breast milk | Grant |
Application Date | 7/18/2019 |
---|---|
Grant Date | 8/6/2024 |
Title | |
Related Topics | Breastfeeding, Fluid dynamics, Fluid mechanics, Infant feeding, Breast milk |
Status | Grant |
Latest Coroflo News
Sep 12, 2024
News provided by Share this article Share toX NEW YORK, Sept. 12, 2024 /PRNewswire/ -- Report with the AI impact on market trends- The global femtech devices market size is estimated to grow by USD 8.6 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 12.93% during the forecast period. Increase in rate of infertility and obesity-related cases in women is driving market growth, with a trend towards integration of ai and machine learning (ml) technologies in femtech devices. However, lack of investment and insufficient research and development poses a challenge. Key market players include Ava AG, Bellabeat Inc., Chiaro Technology Ltd., Coroflo Ltd, Embr Labs, Endomagnetics Ltd., HeraMED, iPulse Medical Ltd., iSono Health, Inc., Lady Technologies, Inc., Medela AG, Natural Cycles Nordic AB, Perifit Global, Roman Health Ventures Inc., Tempdrop Ltd., Thermaband Inc, Valley Electronics AG, viO HealthTech Ltd, Willow Innovations Inc., and Winx Health, Inc.. Technavio has announced its latest market research report titled Global femtech devices market 2024-2028 AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now Forecast period Key companies profiled Ava AG, Bellabeat Inc., Chiaro Technology Ltd., Coroflo Ltd, Embr Labs, Endomagnetics Ltd., HeraMED, iPulse Medical Ltd., iSono Health, Inc., Lady Technologies, Inc., Medela AG, Natural Cycles Nordic AB, Perifit Global, Roman Health Ventures Inc., Tempdrop Ltd., Thermaband Inc, Valley Electronics AG, viO HealthTech Ltd, Willow Innovations Inc., and Winx Health, Inc. Key Market Trends Fueling Growth The integration of Artificial Intelligence (AI) and Machine Learning (ML) technologies in femtech devices is revolutionizing the global femtech devices market. These technologies enable the development of sophisticated devices and platforms that offer personalized insights, predictive analytics, and enhanced user experiences in various aspects of women's health. AI and ML are primarily used in menstrual tracking and fertility monitoring. Advanced algorithms analyze data inputs such as menstrual cycle length, basal body temperature, and symptoms to predict ovulation, fertility windows, and potential reproductive health issues. Furthermore, AI-powered virtual assistants and chatbots integrated into femtech devices enhance the accessibility of women's health information and support. These intelligent assistants provide real-time responses to user queries, offer personalized health insights based on input data, and suggest lifestyle modifications to improve overall well-being. AI-driven analysis of wearable device data enables proactive health monitoring and early detection of underlying health conditions. For instance, AI algorithms identify patterns in sleep quality, heart rate variability, and activity levels to assess mental health indicators such as stress and anxiety trends. By alerting users to potential issues and prompting them to seek appropriate care, AI-enhanced femtech devices promote proactive management of mental health and overall wellness. Additionally, ML algorithms in fertility treatment and reproductive health platforms optimize personalized care plans and treatment outcomes for women undergoing assisted reproductive technologies. By leveraging historical and real-time data, ML predicts individual responses to treatments, refines medication dosages, and improves success rates of fertility interventions, ultimately enhancing the quality of care provided to women seeking reproductive assistance. These factors are expected to fuel the growth of the femtech devices market during the forecast period. The Femtech market is booming with innovative devices and solutions catering to the unique needs of women's health. Key trends include devices for endometriosis management, breast cancer detection, and fertility tracking apps. Healthcare technology and digital health platforms are revolutionizing health management tools with personalized diagnostics and real-time health monitoring. Smart breast pumps and breastfeeding solutions are transforming mHealth for new mothers. Telemedicine and digital health solutions offer increased healthcare access for chronic disease prevention and postpartum depression (PPD) management. AI and ML are driving advancements in female health, from reproductive health to pregnancy and menstrual cycle tracking. Wearable devices and smart devices are making healthcare more accessible and convenient for the growing female population. Overall, Femtech is revolutionizing general healthcare by addressing the specific needs of women and improving overall healthcare management. Insights on how AI is driving innovation, efficiency, and market growth- Request Sample! Market Challenges The Femtech devices market, focused on technological innovations for women's health, faces challenges in terms of funding and research. Historically, investors have overlooked this sector, viewing it as a niche area. Despite recent growth in interest and investment, particularly in fertility, maternal health, and sexual well-being, femtech's overall funding remains behind other healthcare industries. High costs of implementing digital solutions and limited representation in clinical trials hinder progress. Incomplete data on women's health impedes effective product creation, negatively impacting the market's growth during the forecast period. The Femtech market is revolutionizing women's healthcare by integrating technology into female biological needs. This sector focuses on smart devices for women's health, including pregnancy, fertility, menstrual cycle, and reproductive health. With a large female population, there's a growing demand for wearable devices, telehealth services, and diagnostic services. Challenges include addressing mental health concerns like postpartum depression (PPD) and menopause management through therapeutic services and teletherapy. Femtech companies like Clue, Oura Ring, and Maven Clinic offer period tracking, ovulation tracking, menopause management, and personalized health advice. These health-oriented smart rings and menstrual health apps provide valuable health-related information, enabling women to monitor their well-being and fitness. Investors, such as General Catalyst, have shown interest, with Series E funding for Femtech companies. AI and medical professionals collaborate to create health applications and diagnostic services, making medical care more accessible. Direct-to-Consumer (DTC) Femtech solutions and mobile applications offer convenience and affordability. Overall, Femtech is transforming women's healthcare, focusing on mental health, menstrual health, and reproductive health. Insights into how AI is reshaping industries and driving growth- Download a Sample Report Segment Overview Product Type 2.2 Reproductive health and contraception 2.3 Menstrual health 2.5 Others 3.4 Rest of World (ROW) 1.1 Wearable devices- The Femtech devices market refers to technology specifically designed for women's health and wellness. This sector includes wearable tech, mobile apps, and connected devices for menstrual cycle tracking, fertility management, and telemedicine consultations. Companies like Moody, Ava, and Clue lead this market, providing valuable insights and services for women's health management. These tools enable better understanding of menstrual cycles, fertility, and overall wellbeing, enhancing women's control over their health. Download complimentary Sample Report to gain insights into AI's impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2018 - 2022) Research Analysis The Femtech market is revolutionizing women's healthcare by integrating technology into female biological needs. This sector focuses on women's health, pregnancy, fertility, menstrual cycle, reproductive health, and well-being. Smart devices such as wearable tech, menstrual health apps, and AI-powered platforms are transforming the way women manage their health. The global female population is the primary target, with medical care, telehealth services, and mental health solutions catering to various stages of life. Teletherapy, menopause, menstrual health, and personalized diagnostics are some areas of growth. Companies are raising funds, like Maven Clinic's Series E funding from investors like General Catalyst, to expand their offerings. Femtech's digital health platforms provide personalized advice through fertility tracking apps, breastfeeding solutions, mHealth, and telemedicine. AI plays a significant role in personalized diagnostics and digital health solutions. Market Research Overview Femtech, a revolutionary segment of healthcare technology, focuses on addressing the unique biological needs of women through technology. This market encompasses smart devices, wearable technology, and digital health solutions designed for women's health, pregnancy, fertility, menstrual cycle, reproductive health, and menopause management. The Femtech market caters to the female population, offering medical care, telehealth services, diagnostic services, monitoring services, and therapeutic services. Period tracking, ovulation tracking, menopause management, and mental health resources are some of the key areas where Femtech is making a significant impact. Health-oriented smart rings, such as the Clue app and Oura ring, are popular Femtech devices that provide personalized health advice and real-time health monitoring. Femtech also includes teletherapy services for postpartum depression (PPD) and menopause management. Medical professionals and health-related information are essential components of this market, which offers digital health platforms, personalized diagnostics, and AI-powered breast cancer detection solutions. The Femtech market is expanding rapidly, with DTC health applications, mHealth, telemedicine, and digital health solutions gaining popularity for women's fitness, well-being, and chronic disease prevention. Table of Contents: About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts
Coroflo Frequently Asked Questions (FAQ)
When was Coroflo founded?
Coroflo was founded in 2016.
Where is Coroflo's headquarters?
Coroflo's headquarters is located at Old Finglas Road, Dublin 11.
What is Coroflo's latest funding round?
Coroflo's latest funding round is Unattributed - II.
How much did Coroflo raise?
Coroflo raised a total of $7.59M.
Who are the investors of Coroflo?
Investors of Coroflo include Brian Caulfield, Shemas Eivers, Horizon 2020, European Commission, Google Adopt a Startup and 5 more.
Who are Coroflo's competitors?
Competitors of Coroflo include Raydiant Oximetry and 2 more.
Loading...
Compare Coroflo to Competitors
Pera Labs specializes in AI fertility solutions and reproductive health services within the health tech industry. The company offers a range of services including fertility and genomic testing, dietary supplements for fertility, and reproductive health counselling. Pera Labs primarily serves individuals and couples seeking fertility treatments and reproductive wellness. It was founded in 2018 and is based in Philadelphia, Pennsylvania.
Nanit specializes in smart baby monitoring technology within the consumer electronics sector. The company offers products that enable parents to track their baby's sleep, breathing, and overall wellness through a connected camera and app, providing insights and analytics to support child development. Nanit's solutions cater to the needs of modern parents seeking data-driven tools for infant care and development. It was founded in 2014 and is based in New York, New York.
Bloomlife operates as a women's health company focused on improving maternal health through technology in the healthcare sector. The company offers remote patient monitoring and connected devices that provide data analytics for maternal and fetal health, as well as digital health assessments to manage pregnancies. Bloomlife primarily serves healthcare providers and pregnant women. Bloomlife was formerly known as Bloom Technologies. It was founded in 2014 and is based in San Francisco, California.
Baymatob focuses on developing artificial intelligence-guided medical devices for improving health outcomes in obstetrics. The company's main product, Oli, is a labor monitoring device designed to predict and provide early warnings for postpartum hemorrhage, aiming to reduce maternal and infant mortality rates. It primarily serves the healthcare sector, with a focus on maternal health and obstetrics. The company was founded in 2017 and is based in Leichhardt, Australia.
Raydiant Oximetry focuses on developing technologies for childbirth. The company's main offering is Lumerah, a noninvasive sensor technology that directly measures fetal oxygen levels to improve decision-making during labor and potentially reduce cesarean delivery rates. Raydiant Oximetry's products are designed to enhance the safety and outcomes for mothers and babies during childbirth. It was founded in 2016 and is based in San Ramon, California.
Lactation Lab specializes in analyzing breast milk for nutritional content and potential environmental toxins within the health and wellness sector. The company offers a range of breast milk test kits that measure levels of key nutrients, vitamins, and contaminants, providing mothers with actionable insights and personalized recommendations to optimize their milk's quality. Lactation Lab primarily serves the maternal health and infant nutrition sectors. It was founded in 2017 and is based in Santa Monica, California.
Loading...